AIM ImmunoTech Inc
AIM
Market Cap$6.64M
Close$
$-0.17
106.8% downside
Current Fair Value
106.8% downsideOvervalued by 106.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.64 Million |
|---|---|
| Enterprise Value | $8.97 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.31 |
| Beta | 0.45 |
| Outstanding Shares | 759,289 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.12 |
|---|---|
| PEG | -0.22 |
| Price to Sales | - |
| Price to Book Ratio | -0.28 |
| Enterprise Value to Revenue | 74.14 |
| Enterprise Value to EBIT | -0.74 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.31 |
| Debt to Equity | -0.43 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About AIM ImmunoTech Inc
CEO: Thomas Equels